(Q44110888)

English

Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

0 references

author name string

Tohda Y

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Fujimura M

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Taniguchi H

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Takagi K

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Igarashi T

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Yasuhara H

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Takahashi K

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Nakajima S

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1180-1186

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Measuring compliance with inhaled medication in asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Potential masking effects of salmeterol on airway inflammation in asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2002.01440.X

21 January 2018

Identifiers

10.1046/J.1365-2745.2002.01440.X

1 reference

https://api.fatcat.wiki/v0/release/lashrakxbze6nnpeuq7q5kviem

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_lashrakxbze6nnpeuq7q5kviem

1 reference

https://api.fatcat.wiki/v0/release/lashrakxbze6nnpeuq7q5kviem

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/lashrakxbze6nnpeuq7q5kviem

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44110888&oldid=2106690982"